Skip to content
Search

Latest Stories

Submit Guest Post

Coronavirus crisis: Shaheer Sheikh on TV industry’s shutdown

The whole world seems to have come to a complete halt due to the Coronavirus pandemic which has claimed thousands of lives all across the globe. There is no denying the fact that individuals and businesses are going to take a long time to ride out of the impact of the pandemic.

Meanwhile, popular Indian television actor Shaheer Sheikh, who plays the romantic lead on Star Plus’ successful show Yeh Rishtey Hain Pyaar Ke, has given his take on the complete shutdown of the television industry amidst the coronavirus outbreak.

“I am at home for now as we will not be shooting for the next 10-15 days. I think this is a very good step taken by our industry, and I know there are many daily wage earners and that they will suffer, but everyone is going to suffer. At the same time, health is more important and so we need to take care of it for some time to avoid it, so that things can go back to normal as soon as possible,” said the actor.

The Indian film and television industry has stopped all shootings due to the pandemic. Big production houses have postponed the release date of their upcoming ventures in the wake of Coronavirus shutdowns.

On 18th March, Shaheer Sheikh’s show Yeh Rishtey Hain Pyaar Ke completed one year of its successful run on Star Plus. However, the team decided against celebrating the feat keeping in mind the safety and health of the cast and crew in the wake of the Coronavirus pandemic.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less